Twenty-six cases of malignant cystosarcoma phylloides treated at The Charity Hospital of Louisiana were reviewed. No metastases to axillary lymph nodes was observed. The lesion appears to metastasize seldom, if ever, to lymphatics, and axillary dissection is seldom required. Local recurrence was common, however, and justifies wide resection of the primary. Mortality was related more to the size of the lesion than to other findings such as skin or muscle involvement. No lesion with less than three mitoses per ten high power fields and minimal stromal atypia proved fatal. Associated neoplasia was common, particularly in the opposite breast.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0002-9610(78)90236-2DOI Listing

Publication Analysis

Top Keywords

malignant cystosarcoma
8
cystosarcoma phylloides
8
phylloides treatment
4
treatment prognosis
4
prognosis twenty-six
4
twenty-six cases
4
cases malignant
4
phylloides treated
4
treated charity
4
charity hospital
4

Similar Publications

Background: Somatostatin receptors (SSTRs) are expressed in most neuroendocrine neoplasms, particularly in gastroenteropancreatic neuroendocrine tumours, and have been utilised as diagnostic markers and therapeutic targets. The radioiodinated somatostatin analogue 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid- Tyr3-octreotate (DOTATATE) has been employed for SSTR targeting for either diagnostic or therapeutic purposes depending on the labelling with Gallium or Lutetium, respectively. SSTR expression is reported in a subset of breast adenocarcinoma and breast neuroendocrine carcinomas; however, minimal knowledge exists regarding their expression in fibroepithelial (biphasic) breast lesions such as fibroadenoma and phyllodes tumours.

View Article and Find Full Text PDF

Phyllodes tumor is a rare and particular type of breast tumor with features of stromal hyperplasia and malignant potential. The present case is an unusual presentation of a phyllodes tumor with pseudoangiomatous stromal hyperplasia (PASH) which forms an essential part of benign breast disease but is not frequently described in association with phyllodes tumor. A 36-year-old female patient was referred to the hospital with a large breast mass considered to be a benign growth.

View Article and Find Full Text PDF

Background: Sarcomas of the breast are exceedingly rare, accounting for less than 1% of malignant breast tumors, with primary rhabdomyosarcomas being even rarer. Due to the scarcity of reported cases, the imaging characteristics of breast rhabdomyosarcoma are not well-defined, making diagnosis challenging, especially in adolescents.

Case Description: We present the case of a 17-year-old female diagnosed with embryonal rhabdomyosarcoma following a comprehensive workup for right breast masses.

View Article and Find Full Text PDF
Article Synopsis
  • Phyllodes tumours are rare breast tumors, making up only 1% of breast tumors, characterized primarily by their fibroepithelial composition.
  • A 20-year-old woman experienced significant growth in a borderline phyllodes tumor, which led to multiple surgeries, including a mastectomy, due to metastasis and persistent recurrence.
  • Despite aggressive treatment including surgery, radiotherapy, and chemotherapy, the patient's condition worsened, highlighting the importance of obtaining clear surgical margins to reduce recurrence risks.
View Article and Find Full Text PDF

Key Clinical Message: Early and complete surgical resection is the most important therapeutic and diagnostic measure. Adjuvant radiation is suggested for malign phyllode tumors, phyllode tumors larger than 10 cm or those with a low distance to the resection margins.

Abstract: Phyllodes tumors are rare fibroepithelial tumors of the breast.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!